A new cancer Action Guide is equipping key stakeholders with targeted strategies to enhance efficiency and patient-centred care.

Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement next-generation ...

A topical treatment combining calcipotriol and 5-FU shows promise in reducing premalignant lesions and lowering skin cancer risk by activating Th2 immunity.

The Quezon City government in partnership with the Philippine Cancer Society (PCS) beefed up its cancer care programs and ...

Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement ...

While genetic testing rates for advanced ovarian cancer have increased, gaps in physician understanding and confidence in interpreting results may limit optimal biomarker-driven treatment and patient ...

By the late 1990s, scientists had managed to identify drugs that worked against mutant proteins that function in specific signaling pathways that cancer cells rely on—a step that ushered in a ...

Ms Christian revealed that Manx Care has consistently missed the 62-day referral-to-treatment standard, which requires 85 percent of patients to begin treatment within 62 days of a suspected cancer ...

Therapeutically targeting this pathway could potentially enhance the immune response to cancer. A research team at Memorial Sloan Kettering Cancer Center (MSK) has made new insights into how the body ...